La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Extendicare Croissance future

Future contrôle des critères 0/6

Extendicare devrait augmenter son chiffre d'affaires de 2.8% par an.

Informations clés

n/a

Taux de croissance des bénéfices

n/a

Taux de croissance du BPA

Healthcare croissance des bénéfices	60.6%
Taux de croissance des recettes	2.8%
Rendement futur des capitaux propres	n/a
Couverture par les analystes	Low
Dernière mise à jour	19 Aug 2024

Mises à jour récentes de la croissance future

Recent updates

There May Be Underlying Issues With The Quality Of Extendicare's (TSE:EXE) Earnings

Mar 16

Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04

Oct 19

Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.04

Sep 21

Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04

Aug 24

Extendicare's (TSE:EXE) Dividend Will Be CA$0.04

Jul 20

Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.04

Jun 20

Extendicare (TSE:EXE) Has Affirmed Its Dividend Of CA$0.04

May 18

Is Extendicare (TSE:EXE) Using Too Much Debt?

May 11

Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.04

Jan 20

Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.04

Aug 17

Prévisions de croissance des bénéfices et des revenus

TSX:EXE - Estimations futures des analystes et données financières antérieures (CAD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
12/31/2026	1,494	N/A	15	N/A	3
12/31/2025	1,461	N/A	13	N/A	3
12/31/2024	1,426	N/A	-2	N/A	2
6/30/2024	1,388	59	27	110	N/A
3/31/2024	1,347	35	-12	93	N/A
12/31/2023	1,305	34	-106	23	N/A
9/30/2023	1,265	18	-100	36	N/A
6/30/2023	1,252	1	-99	30	N/A
3/31/2023	1,241	3	-97	17	N/A
12/31/2022	1,222	-5	-3	99	N/A
9/30/2022	1,217	-1	-18	81	N/A
6/30/2022	1,193	6	34	116	N/A
3/31/2022	1,178	4	46	124	N/A
12/31/2021	1,167	8	-6	59	N/A
9/30/2021	1,114	27	31	91	N/A
6/30/2021	1,126	59	65	110	N/A
3/31/2021	1,127	49	53	89	N/A
12/31/2020	1,104	42	88	121	N/A
9/30/2020	1,141	31	56	80	N/A
6/30/2020	1,127	2	26	54	N/A
3/31/2020	1,129	15	19	51	N/A
12/31/2019	1,132	15	12	45	N/A
9/30/2019	1,130	1	3	41	N/A
6/30/2019	1,127	4	-16	27	N/A
3/31/2019	1,123	6	-8	42	N/A
12/31/2018	1,120	8	-11	39	N/A
9/30/2018	1,113	27	-5	49	N/A
6/30/2018	1,106	26	-1	52	N/A
3/31/2018	1,100	30	N/A	46	N/A
12/31/2017	1,097	32	N/A	47	N/A
9/30/2017	1,093	35	N/A	54	N/A
6/30/2017	1,088	38	N/A	33	N/A
3/31/2017	1,075	38	N/A	33	N/A
12/31/2016	1,061	31	N/A	0	N/A
9/30/2016	1,046	25	N/A	1	N/A
6/30/2016	1,032	27	N/A	-8	N/A
3/31/2016	1,005	21	N/A	11	N/A
12/31/2015	943	24	N/A	53	N/A
9/30/2015	894	24	N/A	52	N/A
6/30/2015	848	16	N/A	76	N/A
3/31/2015	815	14	N/A	71	N/A
12/31/2014	816	11	N/A	86	N/A
9/30/2014	-118	2	N/A	93	N/A
6/30/2014	183	4	N/A	110	N/A
3/31/2014	480	9	N/A	110	N/A
12/31/2013	784	10	N/A	98	N/A
9/30/2013	2,002	26	N/A	115	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Données insuffisantes pour déterminer si la croissance des bénéfices prévue de EXE est supérieure au taux d'épargne ( 2.2% ).

Bénéfices vs marché: Données insuffisantes pour déterminer si les bénéfices de EXE devraient croître plus rapidement que le marché Canadian

Croissance élevée des bénéfices: Données insuffisantes pour déterminer si les bénéfices de EXE devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de EXE ( 2.8% par an) devrait croître plus lentement que le marché de Canadian ( 6.9% par an).

Croissance élevée des revenus: Le chiffre d'affaires de EXE ( 2.8% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de EXE devrait être élevé dans 3 ans

Extendicare Croissance future

Future contrôle des critères 0/6

Informations clés

Mises à jour récentes de la croissance future

Price target increased by 10% to CA$9.17

Price target increased by 10% to CA$8.00

Recent updates

Extendicare's (TSE:EXE) Dividend Will Be CA$0.04

Dividend of CA$0.04 announced

Price target increased by 10% to CA$9.17

Second quarter 2024 earnings released: EPS: CA$0.30 (vs CA$0.023 in 2Q 2023)

Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.04

Dividend of CA$0.04 announced

Extendicare Inc. Announces July 2024 Cash Dividend, Payable on August 15, 2024

Extendicare Inc. to Report Q2, 2024 Results on Aug 12, 2024

Senior Vice President of ParaMed & CTO recently bought CA$98k worth of stock

Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.04

Dividend of CA$0.04 announced

Extendicare Inc. Declares Cash Dividend for the Month of June 2024, Payable on July 15, 2024

Extendicare (TSE:EXE) Is Paying Out A Dividend Of CA$0.04

Extendicare Inc. Announces Alan Hibben Not Been Re-Elected as A Director

Dividend of CA$0.04 announced

First quarter 2024 earnings released: EPS: CA$0.16 (vs CA$0.14 in 1Q 2023)

Extendicare Inc. Declares Cash Dividend for the Month of May 2024, Payable on June 17, 2024

Upcoming dividend of CA$0.04 per share

Extendicare Inc., Annual General Meeting, May 23, 2024

Dividend of CA$0.04 announced

Extendicare Inc. Declares Cash Dividend for the Month of April 2024, Payable on May 15, 2024

Extendicare Inc. to Report Q1, 2024 Results on May 15, 2024

CEO, President & Director exercised options to buy CA$450k worth of stock.

Upcoming dividend of CA$0.04 per share

There May Be Underlying Issues With The Quality Of Extendicare's (TSE:EXE) Earnings

Price target increased by 10% to CA$8.00

Dividend of CA$0.04 announced

Full year 2023 earnings released: EPS: CA$0.40 (vs CA$0.051 loss in FY 2022)

Extendicare Inc. Declares Cash Dividend for the Month of March 2024, Payable on April 15, 2024

Upcoming dividend of CA$0.04 per share

Dividend of CA$0.04 announced

Extendicare Inc. Declares Cash Dividend for the Month of February 2024, Payable on March 15, 2024

Upcoming dividend of CA$0.04 per share at 6.7% yield

Extendicare Inc. to Report Q4, 2023 Results on Mar 07, 2024

Extendicare Inc. Declares Cash Dividend for the Month of December 2023, Payable on January 15, 2024

Independent Director recently bought CA$99k worth of stock

Upcoming dividend of CA$0.04 per share at 7.4% yield

Extendicare Inc. Declares Cash Dividend for the Month of November 2023, Payable on December 15, 2023

Third quarter 2023 earnings released: EPS: CA$0.14 (vs CA$0.049 loss in 3Q 2022)

Upcoming dividend of CA$0.04 per share at 7.9% yield

Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of October 2023, Payable on November 15, 2023

Extendicare Inc. to Report Q3, 2023 Results on Nov 09, 2023

Upcoming dividend of CA$0.04 per share at 7.8% yield

Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.04

Extendicare Inc. Announces Cash Dividend for the September 2023, Payable on October 16, 2023

Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04

Upcoming dividend of CA$0.04 per share at 7.4% yield

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: CA$0.02 (vs CA$0.039 in 2Q 2022)

Extendicare Inc. Declares Cash Dividend for the Month of August 2023, Payable on September 15, 2023

Extendicare Inc. (TSX:EXE) completed the acquisition of a 15 percent stake in a Portfolio of 24 Long Term Care Homes from Revera Inc. and Axium Infrastructure Inc.

Upcoming dividend of CA$0.04 per share at 6.5% yield

Extendicare's (TSE:EXE) Dividend Will Be CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of July 2023, Payable on August 15, 2023

Extendicare Inc. to Report Q2, 2023 Results on Aug 10, 2023

Upcoming dividend of CA$0.04 per share at 6.7% yield

Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of June 2023, Payable on July 17, 2023

Insufficient new directors

Independent Director recently bought CA$108k worth of stock

Upcoming dividend of CA$0.04 per share at 6.6% yield

Extendicare (TSE:EXE) Has Affirmed Its Dividend Of CA$0.04

Senior Vice President of ParaMed & CTO recently bought CA$206k worth of stock

Is Extendicare (TSE:EXE) Using Too Much Debt?

First quarter 2023 earnings released: EPS: CA$0.14 (vs CA$0.045 in 1Q 2022)

Upcoming dividend of CA$0.04 per share at 7.4% yield

CEO, President & Director recently bought CA$189k worth of stock

Upcoming dividend of CA$0.04 per share at 7.9% yield

CEO, President & Director exercised options to buy CA$258k worth of stock.

Full year 2022 earnings released: CA$0.051 loss per share (vs CA$0.10 profit in FY 2021)

Upcoming dividend of CA$0.04 per share at 7.1% yield

Extendicare Inc. Declares Dividend for the Month of February 2023, Payable on March 15, 2023